Windward Bio Group AG Common Shares WWB

$24.67 +2.75% at last close
Market Cap$1.39 billion
P/E Ratio—
Div Yield—
Volume89.4K
52-Week Range $18.35$33.98

Key Stats

Today's Range
$23.16 – $25.00
50-Day Range
$18.35 – $33.98
52-Week Range
$18.35 – $33.98
Volume
89K shs
Average Volume
423K shs
Market Cap
$1.39 billion
P/E Ratio
—
Dividend Yield
—

About Windward Bio Group AG Common Shares

Windward Bio Group AG is a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, including asthma, COPD, and atopic dermatitis. Its flagship program is WIN378, a potentially novel, long-acting, anti-TSLP monoclonal antibody. The pipeline also includes WIN027, a clinical-stage, long-acting anti-TSLPxIL-13 bi-specific, which has therapeutic application across immunological diseases.

Exchange
XNAS
Listed
2026-11-13

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.